BioConsortia has filed a notice of an exempt offering of securities to raise $15,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, BioConsortia is raising $15,000,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Christina Huben played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About BioConsortia
BioConsortia, Inc. is developing highly effective microbial solutions that enhance plant phenotypes and increase crop yields. We are pioneering the use of directed selection in identifying teams of microbes working like plant breeders and selecting plants based on targeted characteristics, then isolating the associated microbial community. Our proprietary Advanced Microbial Selection (AMS) process enriches the crop microbiome, allowing us to identify microbes that influence the expression of beneficial traits in plants. We are currently focused on products for fertilizer use efficiency, growth improvement and abiotic tolerance, with plans to invest in biocontrol and metabolite expression with the right partner.
To learn more about BioConsortia, visit http://www.bioconsortia.com/
Contact:
Christina Huben, Chief Financial Officer
530-564-5572
https://www.linkedin.com/in/christina-huben-a032b313/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.